Additional References

References

1. Eric J. Nestler, Steven Hyman, and Robert Malenka (2008) Molecular Neuropharmacology: A Foundation for Clinical Neuroscience, Second Edition, 2nd Edition, Mc Graw Hill Publishers.
2. Bruce Alberts (1998), Essential Cell Biology: An Introduction to the Molecular Biology Of The Cell,   Garland Publishers.
3. Stefan Offermanns, Walter Rosenthal (2009) Encyclopedia of Molecular Pharmacology, Volume 1 and 2, 2nd Edition, Sringer.
4. Annette Gilchrist (2008) GPCR Molecular Pharmacology and Drug Targeting: Shifting Paradigms and New Directions, 1st Edition, Wiley.
5. ack R. Cooper, Floyd E. Bloom, Robert H. Roth (2003), The Biochemical Basis of Neuropharmacology, Oxford University Press.
6. Laurence L. Brunton, John S. Lazo and Keith L. Parker (2009), Goodman & Gilman's The Pharmacological Basis of Therapeutics, 12th Edition McGraw-Hill Professional.
7. Sulabha Pathak, Urmi Palan (2005), Immunology: essential and fundamental, 2nd Edition, Science Publishers Inc.
8. Charles Wiener, Anthony S. Fauci, Eugene Braunwald, Dennis L. Kasper, Stephen L. Hauser, Dan L. Longo, J. Larry Jameson, Joseph Loscalzo (2008), Harrison's Principles of Internal Medicine, Self-Assessment and Board Review, 17th Edition, Mc Graw Hill Publishers.
9. Joseph G. Cannon (2007), Pharmacology for chemists, 2nd Edition, Oxford University Press.
10. J. P. Howard Fee, James G. Bovill (2005), Pharmacology for anaesthesiologists, 1st Edition, Taylor’s and Francis.
11. Bertram G. Katzung, Anthony J. Trevor, Susan B. Masters (2009) Basic and Clinical Pharmacology, 11th Edition, McGraw-Hill Publishers.
12. Fumagalli Guido, Clementi Francesco (Eds). General and Molecular Pharmacology: Principles of Drug Action. Hoboken, New Jersey: Wiley. 2015.
13. Gilchrist Annette (Ed). GPCR Molecular Pharmacology and Drug Targeting: Shifting Paradigms and New Directions. Hoboken, N.J: Wiley. 2010.
14. Salahudeen, Mohammed Saji, Nishtala Prasad S. 2017. Review: An overview of pharmacodynamic modelling, ligand-binding approach and its application in clinical practice. Saudi Pharmaceutical Journal, February 25(2):165-175.
15. Lewis R (Ed). Human Genetics: Concepts and Applications, Ninth Edition McGraw−Hill. 2010.
16. John C. Foreman, Torben Johansen, Alasdair J. Gibb. (Eds). Textbook of receptor pharmacology, 3rd Edition. Boca Raton: CRC Press, 2011.
17. Gabor G. Kovacs (2016). Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine, International journal of molecular sciences, 17(189):1-33.
18. Masato Hasegawa (2016). Molecular Mechanisms in the Pathogenesis of Alzheimer’s disease and Tauopathies-Prion-Like Seeded Aggregation and Phosphorylation, Biomolecules 6(24):1-12.
19. Megha Agrawal, Abhijit Biswas (2015). Molecular diagnostics of neurodegenerative disorders, Frontiers in Molecular Biosciences, 2(54):1-10.
20. Masahisa Katsuno, Hirohisa Watanabe, Fumiaki Tanaka, Gen Sobue (2013). Translational research on disease-modifying therapies for neurodegenerative diseases, Neurology and Clinical Neuroscience, 1:3–10.
21. Vijay K Ramanan, Andrew J. Saykin (2013). Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer’s disease, Parkinson’s disease, and related disorders, American Journal of Neurodegenerative Disease, 2(3):145-175.
22. Patrick Hickey, Mark Stacy (2011). Available and emerging treatments for Parkinson’s disease: a review, Drug Design, Development and Therapy, 5: 241–254.
23. Wyatt RJ, Julian BA. IgA nephropathy (2013). New England Journal of Medicine, 368(25):2402-14.
24. Loeffler I, Wolf G (2014). Transforming growth factor-β and the progression of renal disease. Nephrology Dialysis Transplantation, 29(suppl 1):i37-45
25. Sun YM, Su Y, Li J, Wang LF (2013). Recent advances in understanding the biochemical and molecular mechanism of diabetic nephropathy. Biochemical and biophysical research communications, 433(4):359-61.
26. Eddy AA (2014). Overview of the cellular and molecular basis of kidney fibrosis. Kidney international supplements, 4(1):2-8.
27. Ga-Young Ban, Seun-Joo Ahn, Hye-Soo Yoo , Hae-Sim Park and Young-Min Ye1 (2016). Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis Associated with Acetaminophen Use during Viral Infections. Immune network, 16(4): 256-260.
28. Andrew S. Lee, Michael B. Ellman, Dongyao Yan , Jeffrey S. Kroin , Brian J. Cole , Andre J. van Wijnen, Hee-Jeong I (2013). A current review of molecular mechanisms regarding osteoarthritis and pain. Gene, 527: 440–447.
29. Jose U. Scher (2012). B-Cell Therapies for Rheumatoid Arthritis. Bulletin of the NYU Hospital for Joint Diseases, 70(3):200-3.
30. Christine Stadelmann (2011). Multiple sclerosis as a neurodegenerative disease: pathology, mechanisms and therapeutic implications. Current Opinion in Neurology, 24:224–229.
31. Jinliang Nan, Wei Zhu, MS Rahman, M Liu, Dan Li, Shengan Su, N Zhang, Xinyang Hu, Hong Yu, Mahesh P Gupta, J Wang, Molecular regulation of mitochondrial dynamics in cardiac disease, Biochimica et Biophysica Acta (BBA)- Molecular cell research, (2017) http://doi.org/10.1016/j.bbamcr.2017.03.006
32. William B. Coleman, Gregory J. Tsongalis, Ch: 14, Molecular Basis of Cardiovascular Disease, In: Molecular Pathology: The Molecular Basis of Human Disease, 2009,  1st Edn., Academic Press, Elsevier, London, UK.
33. Dariush Mozaffarian, Jason HY Wu, Omega-3 Fatty Acids and Cardiovascular Disease: Effects on Risk Factors, Molecular Pathways, and Clinical Events, Journal of the American College of Cardiology, Vol 58, Issue 20, 8 November 2011, Pages 2047–2067.
34. Victor Garcia, Ankit Gilani, Brian Shkolnik, Varunkumar Pandey, Frank F Zhang, Rambabu Dakarapu, Shyam K Gandham, N R Reddy, Joan P Graves, Artiom Gruzdev, Darryl C Zeldin, Jorge H Capdevila, John R Falck, Michal L Schwartzman, 20-HETE Signals Through G Protein-Coupled Receptor GPR75 (Gq) to Affect Vascular Function and Trigger Hypertension, Circulation Research (2017) https://doi.org/10.1161/CIRCRESAHA.116.310525
35. Genetics of Congenital Heart Disease: The Glass Half Empty, Akl C. Fahed, Bruce D. Gelb, J. G. Seidman, Christine E. Seidman, Circulation Research, (2013) https://doi.org/10.1161/CIRCRESAHA.112.300853
36. Elsa Bronze-da-Rocha, “MicroRNAs Expression Profiles in Cardiovascular Diseases,” BioMed Research International, vol. 2014, Article ID 985408, 23 pages, 2014. doi:10.1155/2014/985408
37. Adam H.B. (2014), Intertility in practice, 4th Edition, CRC Press.
38. Merrill, R.M. (2010). Reproductive epidemiology : principles and methods, Sudbury, Mass. : Jones and Bartlett Publishers
39. Zhang, Y., et al., (2016). Metformin Ameliorates Uterine Defects in a Rat Model of Polycystic Ovary Syndrome, EBioMedicine, http://dx.doi.org/10.1016/j.ebiom.2017.03.023.
40. Conde-Ferraez, L., Martiez, J.R., Ayora-Talavera and Losa, M.D. (2017). Human papillomavirus and Chlamydia trachomatis infection in gyneco-obstetric outpatients from a mexican hospital. Indian J Med Microbiol., 35(1), 74-79. doi: 10.4103/ijmm.IJMM_15_450.
41. Mengmeng, X., Long C., Zhenguo Y. et al. (2017). Proteomic Analysis of Fetal Ovaries Reveals That Primordial Follicle Formation and Transition Are Differentially Regulated. BioMed Research International, doi:10.1155/2017/6972030.